ARTV
Artiva Biotherapeutics, Inc.
Next earnings Aug 4, 2026 · consensus $-0.64 EPS
Last earnings -13.0% on 2026-05-08
$9.62
▲ +8.95%$9.62▲ +508.86%
over 1Y
L $1.47EODHDH $12.55
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+8.9%
1W+2.9%
1M+19.1%
3M+81.4%
YTD+114.9%
1Y+475.3%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Conservative balance sheet (liabilities/equity 0.19x); but revenue fell -100.0% YoY.
Artiva Biotherapeutics, Inc. shows $0.00 in FY2025 revenue (-100.0% YoY), and -76.3% ROE.
Sources: SEC EDGAR (CIK 0001817241, latest 10-Q filed 2026-05-08) · EODHD · as of 6/26/2026, 6:39:47 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.